Irritable bowel syndrome: current and emerging treatment options

Area of Science:

• Gastroenterology
• Internal Medicine

Background:

• Irritable bowel syndrome (IBS) is a prevalent functional gastrointestinal disorder.
• The exact cause of IBS remains unclear, impacting millions of Americans.
• Existing treatments offer symptomatic relief but do not address underlying pathophysiology.

Purpose of the Study:

• To review current and emerging pharmacological treatments for IBS.
• To highlight the range of medications available for IBS symptom management.

Main Methods:

• Literature review of available and investigational IBS medications.
• Categorization of treatments based on pharmacological action (e.g., antispasmodics, antidepressants, antidiarrheals).

Main Results:

• A variety of medications are used to manage IBS symptoms.
• Pharmacological options include antispasmodics, antidepressants, and antidiarrheals.
• New treatments are under development to address IBS pathophysiology.

Conclusions:

• Pharmacological interventions are a cornerstone of IBS management.
• A diverse range of medications exists to target different IBS symptoms.
• Ongoing research aims to develop more effective IBS therapies.